Arrestin(g) podocyte injury with endothelin antagonism

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 423-425

  Tan, Roderick J ^a   Liu, Youhua ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRASENTAN; BETA CATENIN; DOXORUBICIN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; SITAXSENTAN; SYNAPTOPODIN; TRANSCRIPTION FACTOR SNAIL;

CANCER CELL; CELL CYCLE ARREST; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; EDITORIAL; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; IN VITRO STUDY; OVARY CANCER; PODOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEINURIA; RENAL PROTECTION; RISK FACTOR;

ANIMALS; ARRESTINS; ENDOTHELIN-1; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; PODOCYTES; RECEPTOR, ENDOTHELIN A;

EID: 84896882996     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013111230     Document Type: Editorial

References (15)

1. Levey AS, Stevens LA, Coresh J: Conceptual model of CKD: Applications and implications. Am J Kidney Dis 53[Suppl 3]: S4-S16, 2009
2. Gordon J, Kopp JB: Off the beaten renin-angiotensin-aldosterone system pathway: New perspectives on antiproteinuric therapy. Adv Chronic Kidney Dis 18: 300-311, 2011
3. Buelli S, Rosanò L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, Perico L, Conti S, Rizzo P, Novelli R, Morigi M, Zoja C, Remuzzi G, Bagnato A, Benigni A: β-Arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 25: 523-533, 2014
4. Dhaun N, Goddard J, Webb DJ: The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 17: 943-955, 2006
5. Rosanò L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, Salvati E, Nicotra MR, Natali PG, Bagnato A: Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811, 2009
6. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y: Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299 - 308, 2008
7. Lee VW, Harris DC: Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology (Carlton) 16: 30-38, 2011
8. DeFea KA: Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? Cell Signal 23: 621-629, 2011
9. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011
10. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y: Wnt/betacatenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
11. Kawakami T, Ren SM, Duffield JS: Wnt signalling in kidney diseases: Dual roles in renal injury and repair. J Pathol 229: 221-231, 2013
12. Tan RJ, Zhou L, Zhou D, Lin L, Liu Y: Endothelin receptor A blockade is an ineffective treatment for adriamycin nephropathy. PLoS One 8: e79963, 2013
13. Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A: Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol 297: F1448-F1456, 2009
14. Patinha D, Fasching A, Pinho D, Albino-Teixeira A, Morato M, Palm F: Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors. Am J Physiol Renal Physiol 304: F614-F622, 2013
15. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 82: 322-330, 1988